These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8689107)

  • 1. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer.
    Kriegmair M; Baumgartner R; Lumper W; Waidelich R; Hofstetter A
    Br J Urol; 1996 May; 77(5):667-71. PubMed ID: 8689107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.
    Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L
    Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source.
    Waidelich R; Beyer W; Knüchel R; Stepp H; Baumgartner R; Schröder J; Hofstetter A; Kriegmair M
    Urology; 2003 Feb; 61(2):332-7. PubMed ID: 12597941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
    Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
    BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
    Xiao Z; Brown K; Tulip J; Moore RB
    J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer.
    Waidelich R; Stepp H; Baumgartner R; Weninger E; Hofstetter A; Kriegmair M
    J Urol; 2001 Jun; 165(6 Pt 1):1904-7. PubMed ID: 11371878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
    Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for superficial bladder cancer under local anaesthetic.
    Shackley DC; Briggs C; Gilhooley A; Whitehurst C; O'Flynn KJ; Betts CD; Moore JV; Clarke NW
    BJU Int; 2002 May; 89(7):665-70. PubMed ID: 11966622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid.
    Stocker S; Knüchel R; Sroka R; Kriegmair M; Steinbach P; Baumgartner R
    J Urol; 1997 Jan; 157(1):357-61. PubMed ID: 8976297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
    Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
    Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes.
    Chang SC; MacRobert AJ; Bown SG
    J Urol; 1996 May; 155(5):1749-53. PubMed ID: 8627877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
    Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
    J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium.
    Manyak MJ; Ogan K
    J Endourol; 2003 Oct; 17(8):633-9. PubMed ID: 14622483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate.
    François A; Salvadori A; Bressenot A; Bezdetnaya L; Guillemin F; D'Hallewin MA
    J Urol; 2013 Aug; 190(2):731-6. PubMed ID: 23353049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
    Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
    J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.
    Skyrme RJ; French AJ; Datta SN; Allman R; Mason MD; Matthews PN
    BJU Int; 2005 Jun; 95(9):1206-10. PubMed ID: 15892802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
    Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
    J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.